CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 66 enrolled
Drug / intervention
Varenicline +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02136498
NCT02136498N/ACompleted
CompareCT.gov

Internet-based Medication Adherence Program for Nicotine Dependence Treatment

Kaiser Permanente·interventional·Posted May 13, 2014·Updated Nov 13, 2017

In Brief

A clinical study evaluating Varenicline, Cognitive-behavioral self-help, and 1 other intervention for Smoking Cessation and Medication Adherence. Completed, enrolled 66 participants across 1 site.

Detailed Summary

The purpose of this pilot study is to evaluate the acceptability and feasibility of the proposed smoking cessation intervention (called MyMAP or My Mobile Advice Program).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation, Medication Adherence
CountriesUnited States
CollaboratorsUniversity of Michigan, University of California, Davis

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 13, 2014
Enrollment StartOct 1, 2014
Primary CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.1 years ago

Interventions

Vareniclinedrug

Standard 12 week course of varenicline, provided in both arms

Cognitive-behavioral self-helpbehavioral

Standard self-help education for smoking cessation, delivered via mobile-optimized website accessible via smartphone.

MyMAP (My Mobile Advice Program)behavioral

Same standard self-help intervention as in control arm + automatically-tailored support and advice for managing nicotine withdrawal symptoms + secure messaging with cessation counselor